Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes
Maeve Soto Pérez, Jorge Rodríguez‐Capitán, Juan Antonio Requena-Ibáñez, Carlos G. Santos‐Gallego, M. Urooj Zafar, Ginés Escolar, Donna Mancini, Sumeet S. Mitter, David W. Lam, Johanna Contreras, Icilma Fergus, Farah Atallah-Lajam, Vivian M. Abascal, Anu Lala, Pedro Moreno, Noah Moss, Stamatios Lerakis, Javier Sanz, Valentı́n Fuster, Juan J. Badimón
Topics & Concepts
MedicineHeart failureHeart failure with preserved ejection fractionDiabetes mellitusEjection fractionInternal medicinePlaceboCardiologyPopulationRandomizationClinical trialRandomized controlled trialPathologyEndocrinologyAlternative medicineEnvironmental healthDiabetes Treatment and ManagementHeart Failure Treatment and ManagementCardiovascular Function and Risk Factors